Gateway Investment Advisers LLC Boston Scientific Corp Transaction History

Gateway Investment Advisers LLC

$9 Billion
Q3 2024

A detailed history of Gateway Investment Advisers LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Gateway Investment Advisers LLC holds 605,406 shares of BSX stock, worth $50.9 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

605,406

Previous 605,668 0.04%

Holding current value

$50.9 Million

Previous $46.6 Million 8.77%

% of portfolio

0.56%

Previous 0.53%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$72.96 - $84.0 $19,115 - $22,008	-262 Reduced 0.04%	605,406 $50.7 Million
Q2 2024 Jul 12, 2024	SELL	$67.33 - $77.71 $786,549 - $907,808	-11,682 Reduced 1.89%	605,668 $46.6 Million
Q1 2024 Apr 12, 2024	SELL	$57.6 - $68.62 $2.94 Million - $3.5 Million	-51,001 Reduced 7.63%	617,350 $42.3 Million
Q4 2023 Jan 09, 2024	SELL	$48.64 - $57.81 $472,537 - $561,624	-9,715 Reduced 1.43%	668,351 $38.6 Million
Q3 2023 Oct 19, 2023	SELL	$50.19 - $54.68 $11,895 - $12,959	-237 Reduced 0.03%	678,066 $35.8 Million
Q2 2023 Jul 13, 2023	SELL	$49.72 - $54.64 $5.82 Million - $6.4 Million	-117,120 Reduced 14.72%	678,303 $36.7 Million
Q1 2023 Apr 11, 2023	BUY	$45.09 - $50.03 $4.23 Million - $4.69 Million	93,712 Added 13.35%	795,423 $39.8 Million
Q4 2022 Jan 13, 2023	BUY	$39.56 - $47.22 $13,371 - $15,960	338 Added 0.05%	701,711 $0
Q3 2022 Oct 07, 2022	SELL	$36.71 - $109.66 $20,080 - $59,984	-547 Reduced 0.08%	701,373 $27.2 Million
Q2 2022 Jul 13, 2022	SELL	$35.24 - $47.1 $9,937 - $13,282	-282 Reduced 0.04%	701,920 $26.2 Million
Q1 2022 Apr 14, 2022	SELL	$40.9 - $45.1 $13,169 - $14,522	-322 Reduced 0.05%	702,202 $31.1 Million
Q4 2021 Jan 14, 2022	SELL	$38.07 - $44.87 $65,442 - $77,131	-1,719 Reduced 0.24%	702,524 $29.8 Million
Q3 2021 Oct 22, 2021	SELL	$41.23 - $45.88 $24,985 - $27,803	-606 Reduced 0.09%	704,243 $30.6 Million
Q2 2021 Jul 13, 2021	SELL	$38.58 - $44.24 $3.74 Million - $4.29 Million	-96,910 Reduced 12.09%	704,849 $30.1 Million
Q1 2021 Apr 14, 2021	SELL	$35.27 - $39.67 $9,487 - $10,671	-269 Reduced 0.03%	801,759 $31 Million
Q4 2020 Jan 14, 2021	SELL	$33.15 - $41.97 $811,081 - $1.03 Million	-24,467 Reduced 2.96%	802,028 $28.8 Million
Q3 2020 Oct 19, 2020	SELL	$34.44 - $42.23 $28,103 - $34,459	-816 Reduced 0.1%	826,495 $31.6 Million
Q2 2020 Jul 15, 2020	SELL	$30.19 - $39.11 $57,330 - $74,269	-1,899 Reduced 0.23%	827,311 $29 Million
Q1 2020 Apr 13, 2020	BUY	$25.83 - $45.71 $940,005 - $1.66 Million	36,392 Added 4.59%	829,210 $27.1 Million
Q4 2019 Jan 09, 2020	BUY	$37.87 - $45.37 $110,277 - $132,117	2,912 Added 0.37%	792,818 $35.9 Million
Q3 2019 Oct 15, 2019	SELL	$40.31 - $43.45 $950,267 - $1.02 Million	-23,574 Reduced 2.9%	789,906 $32.1 Million
Q2 2019 Jul 17, 2019	BUY	$34.91 - $42.98 $1.02 Million - $1.26 Million	29,244 Added 3.73%	813,480 $35 Million
Q1 2019 Apr 10, 2019	SELL	$32.91 - $40.75 $71,480 - $88,509	-2,172 Reduced 0.28%	784,236 $30.1 Million
Q4 2018 Jan 14, 2019	BUY	$31.73 - $39.04 $2.09 Million - $2.57 Million	65,956 Added 9.15%	786,408 $27.8 Million
Q3 2018 Oct 16, 2018	SELL	$32.83 - $38.63 $5.26 Million - $6.19 Million	-160,211 Reduced 18.19%	720,452 $27.7 Million
Q2 2018 Jul 11, 2018	SELL	$26.84 - $34.32 $938,943 - $1.2 Million	-34,983 Reduced 3.82%	880,663 $28.8 Million
Q1 2018 Apr 12, 2018	SELL	$25.2 - $28.54 $1.54 Million - $1.74 Million	-61,068 Reduced 6.25%	915,646 $25 Million
Q4 2017 Jan 17, 2018	SELL	$24.79 - $29.8 $4.87 Million - $5.85 Million	-196,468 Reduced 16.75%	976,714 $24.2 Million
Q3 2017 Oct 16, 2017	BUY	$26.26 - $29.17 $30.8 Million - $34.2 Million	1,173,182	1,173,182 $34.2 Million

Others Institutions Holding BSX

# of Institutions

1,469

Shares Held

1.21B

Call Options Held

8.13M

Put Options Held

8.41M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $120B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Investment Advisers LLC with notifications on news.

Account

Gateway Investment Advisers LLC Boston Scientific Corp Transaction History